A Pharmacokinetic Rationale for Proactive Therapeutic Drug Monitoring of Anti-TNF Drugs
- PMID: 29215627
- DOI: 10.1038/ajg.2017.266
A Pharmacokinetic Rationale for Proactive Therapeutic Drug Monitoring of Anti-TNF Drugs
Comment in
-
Response to Reinink.Am J Gastroenterol. 2017 Dec;112(12):1893-1894. doi: 10.1038/ajg.2017.375. Am J Gastroenterol. 2017. PMID: 29215625 No abstract available.
Comment on
-
Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy.Am J Gastroenterol. 2017 May;112(5):673-676. doi: 10.1038/ajg.2017.21. Epub 2017 Feb 21. Am J Gastroenterol. 2017. PMID: 28220781 Review. No abstract available.
-
Therapeutic Drug Monitoring in IBD: Prospective Promise Unfulfilled.Am J Gastroenterol. 2017 May;112(5):670-672. doi: 10.1038/ajg.2017.63. Epub 2017 Mar 21. Am J Gastroenterol. 2017. PMID: 28323274 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources